mRNA Sequencing Market Size, Share, Competitive Landscape and Trend Analysis Report, by Sequencing Types, by Technology and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

mRNA sequencing (mRNA-Seq) is the technique used for examining the transcriptomes of biological processes, disease states, and over a broad range of study designs. mRNA-Sequencing presents a comprehensive picture of the coding transcriptome. mRNA-Sequencing is an accurate & highly sensitive technique of quantifying gene expression, can identify gene fusions, novel and known transcript isoforms, and other features and allele-specific expression. In addition, mRNA-Sequencing can give strand information, which enable more accurate quantification of overlapping transcripts, increases the percentage of alignable  reads, and allows the detection of antisense expression.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the mRNA sequencing market.

Top Impacting Factors

• Need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics, rise in cases of metabolic disorders, multiple sclerosis, and other diseases, growing demand for RNA Sequencing over the conventional technology, are factors that drive the growth of the mRNA sequencing market.
• In addition, increase in healthcare expenditure; partnerships & collaborations between key players to facilitate development; rise in R&D activities are factors that boost the market growth for mRNA sequencing.
• However, the need for skilled professionals, the huge initial capital investment on infrastructure, problems associated with the storage of sequencing data are factors that hinder the mRNA sequencing market growth.

mRNA Sequencing Market Trends

New product launches to flourish the market

Agreement & product launches are key strategies adopted by players in the RNA sequencing market.

On March 12, 2020, Thermo Fisher Scientific signed an agreement with Janssen Research & Development. The agreement aimed to develop a companion diagnostic (CDx) in the field of oncology.

On October 11, 2018, QIAGEN N.V. launched novel RNA-seq library preparation solutions for next-generation sequencing.

Key Benefits of the Report

• This study presents the analytical depiction of the mRNA sequencing industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the mRNA sequencing market share.
• The current market is quantitatively analyzed to highlight the mRNA sequencing market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the mRNA sequencing market.
• The report provides a detailed mRNA sequencing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the mRNA sequencing Report

• Which are the leading players active in the mRNA sequencing market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the mRNA sequencing market?
• What future projections would help in taking further strategic steps?
• What is "mRNA sequencing"?
• What is "mRNA sequencing" Market prediction in the future?
• Who are the leading global players in the "mRNA sequencing” Market?
• What are the current trends and predicted trends?
• What are the key benefits of the "mRNA sequencing” Market report? 

  mRNA Sequencing Market Report Highlights

Aspects	Details
By Sequencing Types	Product Sequencing Platforms and Consumables Services Data Analysis and Management
By Technology	Sequencing by Synthesis Ion Semiconductor Sequencing Nanopore Sequencing Single Molecule Real Time Sequencing
By End User	Academic and Research Institutes Hospitals and Diagnostic Centers Pharmaceutical & Biotechnology Companies
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Beijing Genomics Institute, Illumina, Tecan Genomics Inc.,, Thermo Fischer Scientific, Agilent Technologies Inc.,, Genomatix GmbH, Sigma Aldrich, Eurofins Scientific, Bio-Rad Laboratories Inc.,, GE Healthcare, F. Hoffmann-La Roche Ltd,, PerkinElmer Inc.